Knockout Tested Rabbit Recombinant Monoclonal HE4 antibody. Suitable for IP, WB, IHC-P and reacts with Human samples. Cited in 15 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
IP | WB | ICC/IF | IHC-P | |
---|---|---|---|---|
Human | Tested | Tested | Not recommended | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/120 | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
HE4, WAP5, WFDC2, WAP four-disulfide core domain protein 2, Epididymal secretory protein E4, Major epididymis-specific protein E4, Putative protease inhibitor WAP5
Knockout Tested Rabbit Recombinant Monoclonal HE4 antibody. Suitable for IP, WB, IHC-P and reacts with Human samples. Cited in 15 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Human Epididymis Protein 4 (HE4) also known as WAP four-disulfide core domain protein 2 (WFDC2) is a small glycoprotein of approximately 13 kDa. HE4 is most highly expressed in the epithelial cells of reproductive tissues like the epididymis but also in tissues such as the respiratory and urogenital tracts. HE4 is secreted into the extracellular space where it functions and is found in normal range in different body fluids. This secreted protein has gained attention due to its use in various diagnostic tests such as the HE4 test and HE4 assay utilizing HE4 antibodies.
HE4 participates in innate immune response and epithelial cell protection. HE4 protein plays a role in the modulation of antiprotease activity as it is involved in inhibiting serine proteases. It is not part of a larger protein complex but interacts with multiple protease signaling pathways. HE4 is often studied for its role in modulating protein activity at epithelial barriers contributing to tissue homeostasis and protective mechanisms against infections.
HE4 interacts within signaling cascades such as the innate immune pathways and extracellular matrix organization. It links to proteins within these pathways like serine proteases and other WFDC family proteins. HE4 influences protease activity regulation an essential component of tissue remodeling and inflammatory response impacting overall pathway dynamics.
HE4 has strong associations with ovarian cancer and endometrial cancer. Its overexpression in these malignancies makes it a valuable biomarker for disease diagnosis and prognosis. HE4 interacts with cancer-related proteins such as CA125 enhancing its utility in combinatory diagnostic approaches. The HE4 test and HE4 ELISA kit price underline its significance in clinical settings for monitoring these cancers where timely detection influences treatment outcomes.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Immunohistochemical analysis of paraffin-embedded Human ovarian carcinoma labeling HE4 with ab200828 at 1/1000 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/500 dilution.
Cytoplasmic staining on Human ovarian carcinoma tissue is observed.
Counter stained with Hematoxylin.
Negative control: Used PBS instead of primary ab, secondary ab is Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051).
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
False colour image of Western blot: Anti-HE4 antibody [EPR16658] staining at 1/2000 dilution, shown in black; Mouse anti-Alpha Tubulin [DM1A] (Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab200828 was shown to bind specifically to HE4. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with Optiblot (ECL reagent Anti-PKC delta (phospho S299) antibody [EPNCI119] ab133456) and imaged with 2 minutes 30 seconds exposure time. Secondary antibodies used were HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) at 1/20000 dilution.
All lanes: Western blot - Anti-HE4 antibody [EPR16658] (ab200828) at 1/2000 dilution
Lane 1: OVCAR-3 cell lysate at 20 µg
Lane 2: K562 cell lysate at 20 µg
Performed under reducing conditions.
Predicted band size: 13 kDa
Observed band size: 20 kDa
HE4 was immunoprecipitated from 1mg of NIH:OVCAR-3 (Human ovary adenocarcinoma ) whole cell lysate with ab200828 at 1/120 dilution.
Western blot was performed from the immunoprecipitate using ab200828 at 1/1000 dilution.
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1: NIH:OVCAR-3 (Human ovary adenocarcinoma) whole cell lysate 10μg.
Lane 2: NIH:OVCAR-3 (Human ovary adenocarcinoma) whole cell lysate following IP.
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab200828 in NIH:OVCAR-3 (human ovary adenocarcinoma) whole cell lysate.
Blocking and dilution buffer and concentration: 5% NFDM/TBST. 10 second exposure.
All lanes: Immunoprecipitation - Anti-HE4 antibody [EPR16658] (ab200828)
Predicted band size: 13 kDa
Observed band size: 17-25 kDa
Blocking/dilution buffer: 5% NFDM/TBST.
The expression profile observed is consistent with what has been described in the literature PMID:15781627
All lanes: Western blot - Anti-HE4 antibody [EPR16658] (ab200828) at 1/1000 dilution
Lane 1: Human ovary cancer whole cell lysate at 10 µg
Lane 2: NIH:OVCAR-3 (Human ovary adenocarcinoma) whole cell lysate at 10 µg
All lanes: Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 13 kDa
Observed band size: 17-25 kDa
Exposure time: 1min
False colour image of Western blot: Anti-HE4 antibody [EPR16658] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (Anti-GAPDH antibody [6C5] - Loading Control ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab200828 was shown to bind specifically to HE4. A band was observed at 20 kDa in treated wild-type OVCAR-3 cell lysates with no signal observed at this size in WFDC2 knockout cell line ab275410 (knockout cell lysate ab275536). To generate this image, wild-type and WFDC2 knockout OVCAR-3 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes: Western blot - Anti-HE4 antibody [EPR16658] (ab200828) at 1/1000 dilution
Lane 1: Wild-type OVCAR-3 Treated Brefeldin A (Brefeldin A Solution (1,000X) ab193369) (5 ug/mL, 4 h), Monensin (Monensin Solution (1,000X) ab193381) (2 uM, 4 h) cell lysate at 20 µg
Lane 2: Wild-type OVCAR-3 Vehicle Control Brefeldin A (Brefeldin A Solution (1,000X) ab193369) (0 ug/mL, 4 h), Monensin (Monensin Solution (1,000X) ab193381) (0 uM, 4 h) cell lysate at 20 µg
Lane 3: WFDC2 knockout OVCAR-3 Treated Brefeldin A (Brefeldin A Solution (1,000X) ab193369) (5 ug/mL, 4 h), Monensin (Monensin Solution (1,000X) ab193381) (2 uM, 4 h) cell lysate at 20 µg
Lane 4: WFDC2 knockout OVCAR-3 Vehicle Control Brefeldin A (Brefeldin A Solution (1,000X) ab193369) (0 ug/mL, 4 h), Monensin (Monensin Solution (1,000X) ab193381) (0 uM, 4 h) cell lysate at 20 µg
Performed under reducing conditions.
Observed band size: 20 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com